PATENT CLAIM ANALYSIS

Application Number: 16083209
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["546", "274700"]

Abstract:
A mesylate salt of the compound of formula (I), the preparation method thereof, a pharmaceutical composition containing said salt and the use of said salt in treating diseases mediated by activating and resistance mutations of EGFR, in particular cancers, in mammal, in particular human. The mesylate salt of the compound of formula (I) has a high bioavailability in animal, and can remarkably inhibit the growth of transplanted tumors in animal and show a good safety.

Claim (Index 2):
A method for preparing the mesylate salt of the compound of formula (I) according to  claim 1 , wherein, in a solvent, the compound of formula (I) and methanesulfonic acid are directly reacted to give the mesylate salt.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.77551
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16083210', '15329044', '15745187', '15504187', '15603789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7416287446931922
- 35 USC 102 Novelty (BERT): 0.5244777964827736
- Combined Prediction Score: 0.7199136498721503
- Mean Citation Score: 249.111838
- Max Citation Score: 310.9096
- Similarity Product: 216.02744579525

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test